Recombinant Factor VIII Market Report

Global Recombinant Factor VIII Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：168
  • REPORT CODE：GMM768585
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Recombinant Factor VIII market report explains the definition, types, applications, major countries, and major players of the Recombinant Factor VIII market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Biogen

    • Octapharma

    • Bayer

    • Pfizer

    • CSL

    • NovoNordisk

    • Shire (Baxter)

    By Type:

    • 200IU

    • 250IU

    By End-User:

    • Hospital

    • Pharmacy

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Recombinant Factor VIII Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Recombinant Factor VIII Outlook to 2028- Original Forecasts

    • 2.2 Recombinant Factor VIII Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Recombinant Factor VIII Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Recombinant Factor VIII Market- Recent Developments

    • 6.1 Recombinant Factor VIII Market News and Developments

    • 6.2 Recombinant Factor VIII Market Deals Landscape

    7 Recombinant Factor VIII Raw Materials and Cost Structure Analysis

    • 7.1 Recombinant Factor VIII Key Raw Materials

    • 7.2 Recombinant Factor VIII Price Trend of Key Raw Materials

    • 7.3 Recombinant Factor VIII Key Suppliers of Raw Materials

    • 7.4 Recombinant Factor VIII Market Concentration Rate of Raw Materials

    • 7.5 Recombinant Factor VIII Cost Structure Analysis

      • 7.5.1 Recombinant Factor VIII Raw Materials Analysis

      • 7.5.2 Recombinant Factor VIII Labor Cost Analysis

      • 7.5.3 Recombinant Factor VIII Manufacturing Expenses Analysis

    8 Global Recombinant Factor VIII Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Recombinant Factor VIII Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Recombinant Factor VIII Export by Region (Top 10 Countries) (2017-2028)

    9 Global Recombinant Factor VIII Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Factor VIII Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 200IU Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 250IU Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Factor VIII Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Recombinant Factor VIII Market Analysis and Outlook till 2022

    • 10.1 Global Recombinant Factor VIII Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Recombinant Factor VIII Consumption (2017-2022)

      • 10.2.2 Canada Recombinant Factor VIII Consumption (2017-2022)

      • 10.2.3 Mexico Recombinant Factor VIII Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.2 UK Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.3 Spain Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.4 Belgium Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.5 France Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.6 Italy Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.7 Denmark Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.8 Finland Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.9 Norway Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.10 Sweden Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.11 Poland Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.12 Russia Recombinant Factor VIII Consumption (2017-2022)

      • 10.3.13 Turkey Recombinant Factor VIII Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.2 Japan Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.3 India Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.4 South Korea Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.5 Pakistan Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.6 Bangladesh Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.7 Indonesia Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.8 Thailand Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.9 Singapore Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.10 Malaysia Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.11 Philippines Recombinant Factor VIII Consumption (2017-2022)

      • 10.4.12 Vietnam Recombinant Factor VIII Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.2 Colombia Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.3 Chile Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.4 Argentina Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.5 Venezuela Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.6 Peru Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.7 Puerto Rico Recombinant Factor VIII Consumption (2017-2022)

      • 10.5.8 Ecuador Recombinant Factor VIII Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Recombinant Factor VIII Consumption (2017-2022)

      • 10.6.2 Kuwait Recombinant Factor VIII Consumption (2017-2022)

      • 10.6.3 Oman Recombinant Factor VIII Consumption (2017-2022)

      • 10.6.4 Qatar Recombinant Factor VIII Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Recombinant Factor VIII Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Recombinant Factor VIII Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Recombinant Factor VIII Consumption (2017-2022)

      • 10.7.2 South Africa Recombinant Factor VIII Consumption (2017-2022)

      • 10.7.3 Egypt Recombinant Factor VIII Consumption (2017-2022)

      • 10.7.4 Algeria Recombinant Factor VIII Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Recombinant Factor VIII Consumption (2017-2022)

      • 10.8.2 New Zealand Recombinant Factor VIII Consumption (2017-2022)

    11 Global Recombinant Factor VIII Competitive Analysis

    • 11.1 Biogen

      • 11.1.1 Biogen Company Details

      • 11.1.2 Biogen Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Biogen Recombinant Factor VIII Main Business and Markets Served

      • 11.1.4 Biogen Recombinant Factor VIII Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Octapharma

      • 11.2.1 Octapharma Company Details

      • 11.2.2 Octapharma Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Octapharma Recombinant Factor VIII Main Business and Markets Served

      • 11.2.4 Octapharma Recombinant Factor VIII Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bayer

      • 11.3.1 Bayer Company Details

      • 11.3.2 Bayer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bayer Recombinant Factor VIII Main Business and Markets Served

      • 11.3.4 Bayer Recombinant Factor VIII Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Details

      • 11.4.2 Pfizer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer Recombinant Factor VIII Main Business and Markets Served

      • 11.4.4 Pfizer Recombinant Factor VIII Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 CSL

      • 11.5.1 CSL Company Details

      • 11.5.2 CSL Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 CSL Recombinant Factor VIII Main Business and Markets Served

      • 11.5.4 CSL Recombinant Factor VIII Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 NovoNordisk

      • 11.6.1 NovoNordisk Company Details

      • 11.6.2 NovoNordisk Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 NovoNordisk Recombinant Factor VIII Main Business and Markets Served

      • 11.6.4 NovoNordisk Recombinant Factor VIII Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Shire (Baxter)

      • 11.7.1 Shire (Baxter) Company Details

      • 11.7.2 Shire (Baxter) Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Shire (Baxter) Recombinant Factor VIII Main Business and Markets Served

      • 11.7.4 Shire (Baxter) Recombinant Factor VIII Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Recombinant Factor VIII Market Outlook by Types and Applications to 2028

    • 12.1 Global Recombinant Factor VIII Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 200IU Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 250IU Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Recombinant Factor VIII Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Recombinant Factor VIII Market Analysis and Outlook to 2028

    • 13.1 Global Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.2.2 Canada Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.2 UK Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.3 Spain Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.5 France Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.6 Italy Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.8 Finland Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.9 Norway Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.11 Poland Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.12 Russia Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.2 Japan Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.3 India Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.3 Chile Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.6 Peru Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.6.3 Oman Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Recombinant Factor VIII Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Recombinant Factor VIII Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Recombinant Factor VIII Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Recombinant Factor VIII

    • Figure of Recombinant Factor VIII Picture

    • Table Global Recombinant Factor VIII Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Recombinant Factor VIII Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 200IU Consumption and Growth Rate (2017-2022)

    • Figure Global 250IU Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Factor VIII Consumption by Country (2017-2022)

    • Table North America Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure United States Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Canada Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Mexico Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure Germany Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure UK Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Spain Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Belgium Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure France Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Italy Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Denmark Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Finland Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Norway Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Sweden Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Poland Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Russia Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Turkey Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table APAC Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure China Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Thailand Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Singapore Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Philippines Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table South America Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure Brazil Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Colombia Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Chile Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Argentina Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Peru Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table GCC Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure Bahrain Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Oman Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Qatar Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table Africa Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure Nigeria Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure South Africa Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Egypt Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Algeria Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table Oceania Recombinant Factor VIII Consumption by Country (2017-2022)

    • Figure Australia Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Table Biogen Company Details

    • Table Biogen Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Recombinant Factor VIII Main Business and Markets Served

    • Table Biogen Recombinant Factor VIII Product Portfolio

    • Table Octapharma Company Details

    • Table Octapharma Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Octapharma Recombinant Factor VIII Main Business and Markets Served

    • Table Octapharma Recombinant Factor VIII Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Recombinant Factor VIII Main Business and Markets Served

    • Table Bayer Recombinant Factor VIII Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Recombinant Factor VIII Main Business and Markets Served

    • Table Pfizer Recombinant Factor VIII Product Portfolio

    • Table CSL Company Details

    • Table CSL Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Recombinant Factor VIII Main Business and Markets Served

    • Table CSL Recombinant Factor VIII Product Portfolio

    • Table NovoNordisk Company Details

    • Table NovoNordisk Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table NovoNordisk Recombinant Factor VIII Main Business and Markets Served

    • Table NovoNordisk Recombinant Factor VIII Product Portfolio

    • Table Shire (Baxter) Company Details

    • Table Shire (Baxter) Recombinant Factor VIII Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire (Baxter) Recombinant Factor VIII Main Business and Markets Served

    • Table Shire (Baxter) Recombinant Factor VIII Product Portfolio

    • Figure Global 200IU Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 250IU Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Table North America Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure Germany Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure China Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure Brazil Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Recombinant Factor VIII Consumption Forecast by Country (2022-2028)

    • Figure Australia Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US